BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Prognosis
22 results:

  • 1. [Prognostic Value of the Expression of Myeloid leukemia Factor 1-Interacting Protein in Gastric Cancer and Its Regulatory Role in Tumor Progression].
    Yang Z; Zhang H; Xu MY; Zhang XF; Wang YY; Ge ST; Geng ZJ; Song X; Li J; Hu JG; Zuo LG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):114-121. PubMed ID: 36647653
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies.
    Illiano M; Colinard M; Taque S; Mallon B; Larue C; Laithier V; Vérité-Goulard C; Sudour-Bonnange H; Faure-Conter C; Coze C; Aerts I; De Maricourt CD; Paillard C; Branchereau S; Brugières L; Fresneau B
    Hepatol Int; 2022 Feb; 16(1):125-134. PubMed ID: 34506008
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
    Rosenthal SH; Gerasimova A; Ma C; Li HR; Grupe A; Chong H; Acab A; Smolgovsky A; Owen R; Elzinga C; Chen R; Sugganth D; Freitas T; Graham J; Champion K; Bhattacharya A; Racke F; Lacbawan F
    PLoS One; 2021; 16(4):e0243683. PubMed ID: 33909614
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
    Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H
    Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.
    Wang CI; Kao HK; Chen TW; Huang Y; Cheng HW; Yi JS; Hung SY; Wu CS; Lee YS; Chang KP
    Oncologist; 2019 Dec; 24(12):e1388-e1400. PubMed ID: 31273053
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Friend leukemia virus integration 1 is a predictor of poor prognosis of breast cancer and promotes metastasis and cancer stem cell properties of breast cancer cells.
    Yan X; Yu Y; Li L; Chen N; Song W; He H; Dong J; Liu X; Cui J
    Cancer Med; 2018 Aug; 7(8):3548-3560. PubMed ID: 29869379
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Aberrant methylation of protocadherin 17 and its prognostic value in pediatric acute lymphoblastic leukemia.
    Uyen TN; Sakashita K; Al-Kzayer LF; Nakazawa Y; Kurata T; Koike K
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27643535
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Analysis of Risk Factors and Therapeutic Strategies for Relapse of leukemia after Allogeneic Hematopoietic Stem Cell Transplantation].
    Shu XY; Yan XF; Dong L; Ding L; Han DM; Xue M; Wang ZD; Yan HM; Wang HX; Duan LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1137-42. PubMed ID: 27531789
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients.
    Fu HY; Wu DS; Zhou HR; Shen JZ
    Hematology; 2014 Sep; 19(6):329-37. PubMed ID: 24164743
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Expression of erythroblastic leukemia viral oncogene homolog 3 (ErbB-3) binding protein-1, matrix metalloproteinases, eplthelial cadherin in adenoid cystic carcinoma and correlation analysis].
    Sun J; Yu YC; Luo YX; Tian Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Dec; 47(12):711-4. PubMed ID: 23328094
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinicopathological significance and prognostic value of LRP16 expression in colorectal carcinoma.
    Xi HQ; Zhao P; Han WD
    World J Gastroenterol; 2010 Apr; 16(13):1644-8. PubMed ID: 20355243
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.
    Park MJ; Taki T; Oda M; Watanabe T; Yumura-Yagi K; Kobayashi R; Suzuki N; Hara J; Horibe K; Hayashi Y
    Br J Haematol; 2009 Apr; 145(2):198-206. PubMed ID: 19245433
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hypermethylation of CpG island in the promoter region of CALCA in acute lymphoblastic leukemia with central nervous system (CNS) infiltration correlates with poorer prognosis.
    Paixão VA; Vidal DO; Caballero OL; Vettore AL; Tone LG; Ribeiro KB; Lopes LF
    Leuk Res; 2006 Jul; 30(7):891-4. PubMed ID: 16712930
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Promoter hypermethylation of p15INK4B, HIC1, cdh1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
    Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
    Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling.
    Olesen LH; Aggerholm A; Andersen BL; Nyvold CG; Guldberg P; Nørgaard JM; Hokland P
    Br J Haematol; 2005 Nov; 131(4):457-67. PubMed ID: 16281935
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
    J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL.
    Olesen LH; Nyvold CG; Aggerholm A; Nørgaard JM; Guldberg P; Hokland P
    Eur J Haematol; 2005 Sep; 75(3):185-92. PubMed ID: 16104873
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Castillejo JA; Agirre X; Barrios M; Navarro G; Molina FJ; Calasanz MJ; Prosper F; Heiniger A; Torres A
    Blood; 2004 Oct; 104(8):2492-8. PubMed ID: 15198948
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ferrant A; Labopin M; Frassoni F; Prentice HG; Cahn JY; Blaise D; Reiffers J; Visani G; Sanz MA; Boogaerts MA; Löwenberg B; Gorin NC
    Blood; 1997 Oct; 90(8):2931-8. PubMed ID: 9376573
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
    Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
    J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.